These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21098325)

  • 21. Uterus didelphys and endometrial carcinoma. A case report.
    Braun RD
    Obstet Gynecol; 1970 Jan; 35(1):93-5. PubMed ID: 5409840
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current state and approaches to increasing the effectiveness of combined radiotherapy of uterine cancer].
    Kholin VV; Stoliarova IV
    Med Radiol (Mosk); 1986 Jul; 31(7):62-9. PubMed ID: 3526078
    [No Abstract]   [Full Text] [Related]  

  • 23. [The CADO-E I type endometrial applicator for RALS therapy].
    Inoue T; Teshima T; Chatani M; Hata K; Ozaki M; Ishiguro S
    Gan No Rinsho; 1986 Apr; 32(4):365-70. PubMed ID: 3712775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A uterus didelphys bicollis, with endometrial cancer in both uteruses.
    Bhalla R; Evans H; Berger L; Crow J; Deheragoda M; Taper Y
    J Obstet Gynaecol; 2005 Nov; 25(8):823-5. PubMed ID: 16368601
    [No Abstract]   [Full Text] [Related]  

  • 25. Endometrial carcinoma with uterus didelphys.
    Thomas AG; Deligdisch L; Goldstein M
    Mt Sinai J Med; 1988 Oct; 55(5):411-3. PubMed ID: 3265185
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advantages of the use of computerized tomography in the study of the distribution of the dose in intracavitary curietherapy].
    Cionini L; Renzi R; Andreucci L; Pirtoli L; Pacini P; Mungai R
    Radiol Med; 1982 Apr; 68(4):267-74. PubMed ID: 7111782
    [No Abstract]   [Full Text] [Related]  

  • 27. [High dose brachytherapy in gynecologic neoplasms. Review of the literature].
    Portaluri M; Raguso A; Parisi S; Paleani Vettori PG
    Minerva Ginecol; 1991 Mar; 43(3):87-95. PubMed ID: 2057107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities of isodose distribution in afterloading contact therapy of non-operated uterine cancer using an applicator tube and a point-shaped radiation source].
    Kloetzer KH; Günther R; Kob D; Walter W
    Radiobiol Radiother (Berl); 1989; 30(1):77-85. PubMed ID: 2727285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of patients with cancer of the corpus uteri using the gamma emitter 137Cs].
    Chernichenko VA; Ivankova VS; Demina EA; Zlochevskaia LL
    Vrach Delo; 1991 Dec; (12):81-3. PubMed ID: 1792785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control of the location of the afterloading applicator using computed tomography and effect on dose distribution in contact therapy of uterine cancer].
    Ehrhardt M; Strietzel M; Herrmann T; Eberhardt HJ; Tellkamp H
    Radiobiol Radiother (Berl); 1986; 27(1):53-8. PubMed ID: 3704129
    [No Abstract]   [Full Text] [Related]  

  • 32. [Formation of isodose plans in the radiotherapy of uterine cancer using computers. II. Calculation of the distribution of radium load].
    Matula P; Futás E; Kunstadt E; Rexová J; Klvana M
    Cesk Radiol; 1983 May; 37(3):132-41. PubMed ID: 6872085
    [No Abstract]   [Full Text] [Related]  

  • 33. [Automatic contour search and segmentation of sonographic transverse sectional pictures of the uterus with regard to optimization of individual isodose planning in uterine cancer].
    Englmeier KH; Hecker R; Hötzinger H; Thiel H
    Strahlentherapie; 1985 May; 161(5):275-80. PubMed ID: 3890275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
    Nguyen C; Souhami L; Roman TN; Clark BG
    Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problems of dose distribution and calculation in endometrium cancer.
    Vujnić V
    Sonderb Strahlenther Onkol; 1988; 82():69-71. PubMed ID: 3394005
    [No Abstract]   [Full Text] [Related]  

  • 36. Endometrial adenocarcinoma in a uterus duplex treated with radiotherapy: a case report and review of literature.
    Nag S; Botstein C; Roseblatt R
    Int J Radiat Oncol Biol Phys; 1980 Dec; 6(12):1759-60. PubMed ID: 7239997
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with FIMAL (fixed manual afterloading) in aberrant positions of the uterus].
    Kazár A; Matula P; Kunstadt E; Rexová J
    Cesk Radiol; 1984 Mar; 38(2):85-9. PubMed ID: 6705119
    [No Abstract]   [Full Text] [Related]  

  • 38. [Restriction of indications and first results with the high-dose rate-afterloading technic (iridium-192)].
    Kucera H; Weghaupt K
    Strahlentherapie; 1984 Aug; 160(8):469-73. PubMed ID: 6474520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fractionated short-time-afterloading with high dose rates in ambulant treatment of inoperable cancer of the uterine corpus].
    Kucera H; Unel N; Weghaupt K
    Geburtshilfe Frauenheilkd; 1983 Jul; 43(7):456-60. PubMed ID: 6194042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of radiotherapy and curietherapy in the treatment of adenocarcinoma of the endometrium].
    Lauche HM
    Rev Fr Gynecol Obstet; 1987 May; 82(5):297-301. PubMed ID: 3602803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.